Phase 4 Crohn's Disease and Colitis Trial, Recruiting (NCT07303686)

Phase 4 Crohn's Disease and Colitis Trial, Recruiting NCT07303686 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT07303686 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your disease is currently in remission based on how you feel (no active symptoms)
Your blood tests show your condition is in remission
A camera examination of your digestive tract shows your condition is in remission
You are not currently taking steroid medications
If you are a woman, you are either past childbearing age/unable to have children, or you are using a medically approved form of contraception
You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

You are currently taking more than one biologic medication (a type of specialist drug used to treat inflammatory conditions)
You have taken steroid tablets or topical steroid treatments within the last 6 months before joining the study
You are currently pregnant
You have issues with alcohol or drug use that could make it difficult to follow the study rules and schedule
You are unable to give consent to participate or are unlikely to be able to attend follow-up appointments as required

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 514-934-1943

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07303686

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase: Phase 4

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 514-934-1943

More information: https://clinicaltrials.gov/study/NCT07303686

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your disease is currently in remission based on how you feel (no active symptoms)
Your blood tests show your condition is in remission
A camera examination of your digestive tract shows your condition is in remission
You are not currently taking steroid medications
If you are a woman, you are either past childbearing age/unable to have children, or you are using a medically approved form of contraception
You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

You are currently taking more than one biologic medication (a type of specialist drug used to treat inflammatory conditions)
You have taken steroid tablets or topical steroid treatments within the last 6 months before joining the study
You are currently pregnant
You have issues with alcohol or drug use that could make it difficult to follow the study rules and schedule
You are unable to give consent to participate or are unlikely to be able to attend follow-up appointments as required

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Registry

ClinicalTrials.gov

Start date

8 October 2025

Est. completion

15 April 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Loss of clinical remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov